185 related articles for article (PubMed ID: 12592337)
1. The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells.
Pettiford SM; Herbst R
Leukemia; 2003 Feb; 17(2):366-78. PubMed ID: 12592337
[TBL] [Abstract][Full Text] [Related]
2. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
Pettiford SM; Herbst R
Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
[TBL] [Abstract][Full Text] [Related]
3. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
Shelly C; Petruzzelli L; Herrera R
Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
[TBL] [Abstract][Full Text] [Related]
4. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
Kim KW; Kim SH; Lee EY; Kim ND; Kang HS; Kim HD; Chung BS; Kang CD
J Biol Chem; 2001 Apr; 276(16):13186-91. PubMed ID: 11278385
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2.
Dorsey JF; Cunnick JM; Mane SM; Wu J
Blood; 2002 Feb; 99(4):1388-97. PubMed ID: 11830491
[TBL] [Abstract][Full Text] [Related]
6. ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells.
Lee CH; Yun HJ; Kang HS; Kim HD
IUBMB Life; 1999 Dec; 48(6):585-91. PubMed ID: 10683762
[TBL] [Abstract][Full Text] [Related]
7. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells.
Herrera R; Hubbell S; Decker S; Petruzzelli L
Exp Cell Res; 1998 Feb; 238(2):407-14. PubMed ID: 9473349
[TBL] [Abstract][Full Text] [Related]
8. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells.
Yen A; Varvayanis S; Platko JD
Cancer Res; 1993 Jul; 53(13):3085-91. PubMed ID: 8363661
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
[TBL] [Abstract][Full Text] [Related]
10. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
Mustelin T; Tautz L; Page R
J Mol Biol; 2005 Nov; 354(1):150-63. PubMed ID: 16226275
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation.
Gronda M; Arab S; Iafrate B; Suzuki H; Zanke BW
Mol Cell Biol; 2001 Oct; 21(20):6851-8. PubMed ID: 11564869
[TBL] [Abstract][Full Text] [Related]
12. Regulation of megakaryocytic differentiation of K562 cells by FosB, a member of the Fos family of AP-1 transcription factors.
Limb JK; Yoon S; Lee KE; Kim BH; Lee S; Bae YS; Jhon GJ; Kim J
Cell Mol Life Sci; 2009 Jun; 66(11-12):1962-73. PubMed ID: 19381435
[TBL] [Abstract][Full Text] [Related]
13. ERK2-Pyruvate Kinase Axis Permits Phorbol 12-Myristate 13-Acetate-induced Megakaryocyte Differentiation in K562 Cells.
Chaman N; Iqbal MA; Siddiqui FA; Gopinath P; Bamezai RN
J Biol Chem; 2015 Sep; 290(39):23803-15. PubMed ID: 26269597
[TBL] [Abstract][Full Text] [Related]
14. Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells.
Jin UH; Ha KT; Kim KW; Chang YC; Lee YC; Ko JH; Kim CH
Biochim Biophys Acta; 2008 May; 1780(5):757-63. PubMed ID: 18339327
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocytic differentiation of K562 cells is associated with changes in the cytoskeletal organization and the pattern of chromatographically distinct forms of phosphotyrosyl-specific protein phosphatases.
Bütler TM; Ziemiecki A; Friis RR
Cancer Res; 1990 Oct; 50(19):6323-9. PubMed ID: 2169344
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
[TBL] [Abstract][Full Text] [Related]
17. Haematopoietic protein tyrosine phosphatase (HePTP) phosphorylation by cAMP-dependent protein kinase in T-cells: dynamics and subcellular location.
Nika K; Hyunh H; Williams S; Paul S; Bottini N; Taskén K; Lombroso PJ; Mustelin T
Biochem J; 2004 Mar; 378(Pt 2):335-42. PubMed ID: 14613483
[TBL] [Abstract][Full Text] [Related]
18. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference.
Bártová E; Harnicarová A; Pacherník J; Kozubek S
Leuk Res; 2005 Aug; 29(8):901-13. PubMed ID: 15978941
[TBL] [Abstract][Full Text] [Related]
19. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.
Tringali C; Lupo B; Cirillo F; Papini N; Anastasia L; Lamorte G; Colombi P; Bresciani R; Monti E; Tettamanti G; Venerando B
Cell Death Differ; 2009 Jan; 16(1):164-74. PubMed ID: 18820643
[TBL] [Abstract][Full Text] [Related]
20. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
